238 related articles for article (PubMed ID: 34455138)
1. Candidiasis in patients with APS-1: low IL-17, high IFN-γ, or both?
Philippot Q; Casanova JL; Puel A
Curr Opin Immunol; 2021 Oct; 72():318-323. PubMed ID: 34455138
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I.
Puel A; Döffinger R; Natividad A; Chrabieh M; Barcenas-Morales G; Picard C; Cobat A; Ouachée-Chardin M; Toulon A; Bustamante J; Al-Muhsen S; Al-Owain M; Arkwright PD; Costigan C; McConnell V; Cant AJ; Abinun M; Polak M; Bougnères PF; Kumararatne D; Marodi L; Nahum A; Roifman C; Blanche S; Fischer A; Bodemer C; Abel L; Lilic D; Casanova JL
J Exp Med; 2010 Feb; 207(2):291-7. PubMed ID: 20123958
[TBL] [Abstract][Full Text] [Related]
3. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines.
Kisand K; Bøe Wolff AS; Podkrajsek KT; Tserel L; Link M; Kisand KV; Ersvaer E; Perheentupa J; Erichsen MM; Bratanic N; Meloni A; Cetani F; Perniola R; Ergun-Longmire B; Maclaren N; Krohn KJ; Pura M; Schalke B; Ströbel P; Leite MI; Battelino T; Husebye ES; Peterson P; Willcox N; Meager A
J Exp Med; 2010 Feb; 207(2):299-308. PubMed ID: 20123959
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to IL-17A may be correlated with the severity of mucocutaneous candidiasis in APECED patients.
Sarkadi AK; Taskó S; Csorba G; Tóth B; Erdős M; Maródi L
J Clin Immunol; 2014 Feb; 34(2):181-93. PubMed ID: 24493573
[TBL] [Abstract][Full Text] [Related]
5. IL-17 and infections.
Ling Y; Puel A
Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():34-40. PubMed ID: 25398490
[TBL] [Abstract][Full Text] [Related]
6. Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhood.
Wolff AS; Sarkadi AK; Maródi L; Kärner J; Orlova E; Oftedal BE; Kisand K; Oláh E; Meloni A; Myhre AG; Husebye ES; Motaghedi R; Perheentupa J; Peterson P; Willcox N; Meager A
J Clin Immunol; 2013 Nov; 33(8):1341-8. PubMed ID: 24158785
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I.
Meloni A; Furcas M; Cetani F; Marcocci C; Falorni A; Perniola R; Pura M; Bøe Wolff AS; Husebye ES; Lilic D; Ryan KR; Gennery AR; Cant AJ; Abinun M; Spickett GP; Arkwright PD; Denning D; Costigan C; Dominguez M; McConnell V; Willcox N; Meager A
J Clin Endocrinol Metab; 2008 Nov; 93(11):4389-97. PubMed ID: 18728167
[TBL] [Abstract][Full Text] [Related]
8. Increased type 1 inflammation in gynecologic cervicovaginal samples in patients with APS-1.
Hetemäki I; Saari V; Yohannes DA; Holopainen E; Holster T; Jokiranta S; Mäyränpää MI; Virtanen S; Mäkitie O; Kekäläinen E; Laakso S
J Allergy Clin Immunol; 2024 Jun; 153(6):1736-1742. PubMed ID: 38395084
[TBL] [Abstract][Full Text] [Related]
9. Increased IL-17A secretion in response to Candida albicans in autoimmune polyendocrine syndrome type 1 and its animal model.
Ahlgren KM; Moretti S; Lundgren BA; Karlsson I; Ahlin E; Norling A; Hallgren A; Perheentupa J; Gustafsson J; Rorsman F; Crewther PE; Rönnelid J; Bensing S; Scott HS; Kämpe O; Romani L; Lobell A
Eur J Immunol; 2011 Jan; 41(1):235-45. PubMed ID: 21182094
[TBL] [Abstract][Full Text] [Related]
10. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.
Meager A; Visvalingam K; Peterson P; Möll K; Murumägi A; Krohn K; Eskelin P; Perheentupa J; Husebye E; Kadota Y; Willcox N
PLoS Med; 2006 Jul; 3(7):e289. PubMed ID: 16784312
[TBL] [Abstract][Full Text] [Related]
11. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis.
Puel A; Cypowyj S; Maródi L; Abel L; Picard C; Casanova JL
Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):616-22. PubMed ID: 23026768
[TBL] [Abstract][Full Text] [Related]
12. The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1.
Oikonomou V; Smith G; Constantine GM; Schmitt MM; Ferré EMN; Alejo JC; Riley D; Kumar D; Dos Santos Dias L; Pechacek J; Hadjiyannis Y; Webb T; Seifert BA; Ghosh R; Walkiewicz M; Martin D; Besnard M; Snarr BD; Deljookorani S; Lee CR; DiMaggio T; Barber P; Rosen LB; Cheng A; Rastegar A; de Jesus AA; Stoddard J; Kuehn HS; Break TJ; Kong HH; Castelo-Soccio L; Colton B; Warner BM; Kleiner DE; Quezado MM; Davis JL; Fennelly KP; Olivier KN; Rosenzweig SD; Suffredini AF; Anderson MS; Swidergall M; Guillonneau C; Notarangelo LD; Goldbach-Mansky R; Neth O; Monserrat-Garcia MT; Valverde-Fernandez J; Lucena JM; Gomez-Gila AL; Garcia Rojas A; Seppänen MRJ; Lohi J; Hero M; Laakso S; Klemetti P; Lundberg V; Ekwall O; Olbrich P; Winer KK; Afzali B; Moutsopoulos NM; Holland SM; Heller T; Pittaluga S; Lionakis MS
N Engl J Med; 2024 May; 390(20):1873-1884. PubMed ID: 38810185
[TBL] [Abstract][Full Text] [Related]
13. Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1.
Lévy R; Escudier A; Bastard P; Briand C; Polivka L; Stoupa A; Talbotec C; Rothenbuhler A; Charbit M; Debray D; Bodemer C; Casanova JL; Linglart A; Neven B
J Clin Immunol; 2023 Dec; 44(1):5. PubMed ID: 38112858
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients.
Garelli S; Dalla Costa M; Sabbadin C; Barollo S; Rubin B; Scarpa R; Masiero S; Fierabracci A; Bizzarri C; Crinò A; Cappa M; Valenzise M; Meloni A; De Bellis AM; Giordano C; Presotto F; Perniola R; Capalbo D; Salerno MC; Stigliano A; Radetti G; Camozzi V; Greggio NA; Bogazzi F; Chiodini I; Pagotto U; Black SK; Chen S; Rees Smith B; Furmaniak J; Weber G; Pigliaru F; De Sanctis L; Scaroni C; Betterle C
J Endocrinol Invest; 2021 Nov; 44(11):2493-2510. PubMed ID: 34003463
[TBL] [Abstract][Full Text] [Related]
15. Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors.
Wolff AS; Kärner J; Owe JF; Oftedal BE; Gilhus NE; Erichsen MM; Kämpe O; Meager A; Peterson P; Kisand K; Willcox N; Husebye ES
J Immunol; 2014 Oct; 193(8):3880-90. PubMed ID: 25230752
[TBL] [Abstract][Full Text] [Related]
16. Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines?
Puel A; Picard C; Cypowyj S; Lilic D; Abel L; Casanova JL
Curr Opin Immunol; 2010 Aug; 22(4):467-74. PubMed ID: 20674321
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune polyglandular syndrome type 1 in Russian patients: clinical variants and autoimmune regulator mutations.
Orlova EM; Bukina AM; Kuznetsova ES; Kareva MA; Zakharova EU; Peterkova VA; Dedov II
Horm Res Paediatr; 2010; 73(6):449-57. PubMed ID: 20407228
[TBL] [Abstract][Full Text] [Related]
18. The heterogeneity of autoimmune polyendocrine syndrome type 1: Clinical features, new mutations and cytokine autoantibodies in a Brazilian cohort from tertiary care centers.
Weiler FG; Peterson P; Costa-Carvalho BT; de Barros Dorna M; Correia-Deur JE; Sader SL; Espíndola-Antunes D; Guerra-Junior G; Dias-da-Silva MR; Lazaretti-Castro M
Clin Immunol; 2018 Dec; 197():231-238. PubMed ID: 30287219
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene.
Wolff AS; Erichsen MM; Meager A; Magitta NF; Myhre AG; Bollerslev J; Fougner KJ; Lima K; Knappskog PM; Husebye ES
J Clin Endocrinol Metab; 2007 Feb; 92(2):595-603. PubMed ID: 17118990
[TBL] [Abstract][Full Text] [Related]
20. Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1.
Meisel C; Akbil B; Meyer T; Lankes E; Corman VM; Staudacher O; Unterwalder N; Kölsch U; Drosten C; Mall MA; Kallinich T; Schnabel D; Goffinet C; von Bernuth H
J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34061776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
